BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33722928)

  • 1. Increased Pulmonary Pneumococcal Clearance after Resolution of H9N2 Avian Influenza Virus Infection in Mice.
    Li J; Wang H; Lian P; Bai Y; Zhang Z; Zhao L; Xu T; Qiao J
    Infect Immun; 2021 May; 89(6):. PubMed ID: 33722928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
    Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
    Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
    Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
    J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klebsiella pneumoniae infection following H9N2 influenza A virus infection contributes to the development of pneumonia in mice.
    Li-Juan L; Kang S; Zhi-Juan L; Dan L; Feng X; Peng Y; Bo-Shun Z; Jiang S; Zhi-Jing X
    Vet Microbiol; 2022 Jan; 264():109303. PubMed ID: 34923246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-4 protects mice against lethal influenza and Streptococcus pneumoniae co-infected pneumonia.
    Peng Y; Wang X; Wang H; Xu W; Wu K; Go X; Yin Y; Zhang X
    Clin Exp Immunol; 2021 Sep; 205(3):379-390. PubMed ID: 34061992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract.
    Manna S; McAuley J; Jacobson J; Nguyen CD; Ullah MA; Sebina I; Williamson V; Mulholland EK; Wijburg O; Phipps S; Satzke C
    mSphere; 2022 Feb; 7(1):e0098421. PubMed ID: 35044807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.
    Kash JC; Walters KA; Davis AS; Sandouk A; Schwartzman LM; Jagger BW; Chertow DS; Li Q; Kuestner RE; Ozinsky A; Taubenberger JK
    mBio; 2011; 2(5):. PubMed ID: 21933918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia.
    van der Sluijs KF; Nijhuis M; Levels JH; Florquin S; Mellor AL; Jansen HM; van der Poll T; Lutter R
    J Infect Dis; 2006 Jan; 193(2):214-22. PubMed ID: 16362885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletions in the neuraminidase stalk region of H2N2 and H9N2 avian influenza virus subtypes do not affect postinfluenza secondary bacterial pneumonia.
    Chockalingam AK; Hickman D; Pena L; Ye J; Ferrero A; Echenique JR; Chen H; Sutton T; Perez DR
    J Virol; 2012 Apr; 86(7):3564-73. PubMed ID: 22278240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.
    van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Pater JM; Florquin S; Goldman M; Jansen HM; Lutter R; van der Poll T
    J Immunol; 2004 Jun; 172(12):7603-9. PubMed ID: 15187140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response.
    Blevins LK; Wren JT; Holbrook BC; Hayward SL; Swords WE; Parks GD; Alexander-Miller MA
    J Immunol; 2014 Nov; 193(10):5076-87. PubMed ID: 25311807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.
    Metzger DW; Furuya Y; Salmon SL; Roberts S; Sun K
    J Infect Dis; 2015 Aug; 212(3):445-52. PubMed ID: 25649173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections.
    Aguilera ER; Lenz LL
    Front Immunol; 2020; 11():105. PubMed ID: 32117259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae.
    Tanaka A; Nakamura S; Seki M; Fukudome K; Iwanaga N; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Clin Vaccine Immunol; 2013 Jul; 20(7):977-85. PubMed ID: 23637040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
    Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
    mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus.
    Chen YY; Huang CT; Li SW; Pan YJ; Lin TL; Huang YY; Li TH; Yang YC; Gong YN; Hsieh YC
    J Biomed Sci; 2021 Aug; 28(1):60. PubMed ID: 34452635
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Sharma-Chawla N; Stegemann-Koniszewski S; Christen H; Boehme JD; Kershaw O; Schreiber J; Guzmán CA; Bruder D; Hernandez-Vargas EA
    Front Immunol; 2019; 10():1864. PubMed ID: 31474978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice.
    Li Y; Xu J; Shi W; Chen C; Shao Y; Zhu L; Lu W; Han X
    Stem Cell Res Ther; 2016 Oct; 7(1):159. PubMed ID: 27793190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.